An overview of the mechanisms of plant ingredients in the treatment of diabetes mellitus

Journal of Medicinal Plants

Volumn 11, Issue 44, 2012, Pages 1-24

  Bathaie, S Z ^a   Mokarizade, N ^a   Shirali, S ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Complement therapy; Diabetes; Ingrediants; Mechanism of action; Medicinal Plants

Indexed keywords

ALKALOID DERIVATIVE; AMINO ACID; CAROTENOID; CROCIN; CROCUS SATIVUS EXTRACT; FLAVONOID; GLUCOSE; IMIDAZOLINE DERIVATIVE; INSULIN; LIGNIN; POLYSACCHARIDE; SAPONIN; STILBENOID; THIOCTIC ACID; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; DIABETES MELLITUS; DIETARY FIBER; GLYCOLYSIS; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MEDICINAL PLANT; REVIEW;

EID: 84877632179     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Review

References (134)

1. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: An overview. Indian J. Medical Res. 2007; 125: 451-72.
2. Matthaei S, Stumvoll M, Kellerer M, Haring HU. Pathophysiology and pharmacological treatment of insulin resistance. Endocrine Rev. 2000; 2: 585-618.
3. Bathaie SZ, Khoshniat E, Mohammadi Nejad A, Arabzadeh A, Khojandi B, Ataie G, et al. A hint to the method selection for binding studies of phenytoin to glycosylated albumin. Daneshvar. 2001; 34: 27-32.
4. Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ, Banasadegh S. Investigation of the Mechanisms Involved in the High-Dose and Long- Term Acetyl Salicylic Acid Therapy of Type I Diabetic Rats. J. Pharmacol. Experiment. Therapeut. 2008; 324: 850-7.
5. Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ. Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat model. Life Sci. 2008; 82: 301-7.
6. Hayden MR, Tyagi SC, Kerklo MM, Nicolls MR. Type 2 diabetes mellitus as a conformational disease. JOP J. Pancreas 2005; 6: 287-302.
7. Venkatesh S, Reddy GD, Reddy BM, Ramesh M and Appa Rao AVN. Antihyperglycemic activity of Caralluma attenuata. Fitoterapia 2003; 74: 274-9.
8. Modi P. Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus. Curr Drug Discov Technol. 2007; 4: 39-47.
9. Hui H, Zhao X, Perfetti R. Structure and function studies of glucagon-like peptide-1 (GLP- 1): the designing of a novel pharmacological agent for the treatment of diabetes. Diabetes Metab. Res. Rev. 2005; 21: 313-31.
10. Michael PK, Asim AB and Robert SB. The Utility of Oral Diabetes Medications in Type 2 Diabetes of the Young. Curr Diab Rev. 2005; 1: 83-92.
11. Dey L, Attele AS and Yuan CS. Alternative therapies for type 2 diabetes. Altern. Med. Rev. 2002; 7: 45-58.
12. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 1999; 131: 281-303.
13. Derek LR. Current therapeutics algorithms for type 2 diabetes. Diabetes Metab. Res. Rev. 2001; 4: 38-49.
14. Marles RJ and Farnsworth N. Antidiabetic Plants and their Active Constituents: An update. Prot. J. Bot. Med. 1996; 1: 85-135.
15. Daniel SF and Norman RF. The Value of Plants Used in Traditional Medicine for Drug Discovery. Environ. Health Perspect. 2001; 109: 69-75.
16. Terne J. Pharmacology and mode of action of hypoglycaemic guanidine derivatives. Oral Hypoglycaemic Agents 1969; 193-245.
17. Nattrass M and Alberti KGMM. Biguanides. Diabetologia 1978; 14: 71-4.
18. Bailey CJ. Biguanides and NIDDM. Diabetes Care 1992; 15: 755-72.
19. Bailey CJ. Metformin-an update. Gen Pharmacol. 1993; 24: 1299-309.
20. Riccio A, Del Prato S, De Kreutzenberg SV and Tiengo A. Glucose and lipid metabolism in non-insulin-dependent diabetes: effect of metformin. Diabete Metab. 1991; 17: 180-4.
21. Rriello G, Misericordia P and Volpi E. Acute antihyperglycemic mechanisms of metformin in NIDDM: evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes Care 1994; 43: 920-8.
22. Hulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA and Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear mag-netic resonance spectroscopy. N. Engl. J. Med. 1990; 322: 223-8.
23. Head GA and Mayorov DN. Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc. Hematol. Agents Med. Chem. 2006; 4: 17-32.
24. Kirtikar KR and Basu BD. Indian Medicinal Plants. Periodical Experts 1993; 1-4.
25. Cooper EJ, Hudson AL, Parker CA and Morgan NG. Effects of the β-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans. Eur. J. Pharmacol. 2003; 482: 189-96.
26. Efendic S, Efanov AM, Berggren PO and Zaitsev SV. Two Generations of Insulinotropic Imidazoline Compounds. Diabetes 2002; 51: S448-S54.
27. Morgan NG and Chan SLF. Imidazoline binding sites in the endocrine pancreas: can they fulfill their potential as targets for the development of new insulin secretagogues? Curr. Pharm. Design. 2001; 7: 1413-31.
28. Hoffman MA, Tritschler HJ, Bierhaus A, Zeigler R, Wahl P and Nawroth P. Lipoate effects on atherogenesis. Fuchs, J. Packer, L. Zimmer, G. eds. Lipoic Acid in Health and Disease, Marcel Dekker, New York, USA. 2000, pp: 321-36.
29. Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic. Biol. Med. 1999; 27: 309-14.
30. Konrad T, Vicini P, Kusterer K, Hoflich A, Assadkhani A, Bohles HJ et al. a-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 1999; 22: 280-7.
31. Estrada DE, Ewart HS, Tsakiridis T, Volchuk A, Ramlal T, Tritschler H, et al. Stimulation of glucose uptake by the natural coenzyme alphalipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes 1996; 45: 1798-804.
32. Konrad D, Somwar R, Sweeney G, Yaworsky K. The Antihyperglycemic Drug a-Lipoic Acid Stimulates Glucose Uptake via Both GLUT4 Translocation and GLUT4 Activation. Diabetes 2001; 50: 1464-71.
33. Vogt T. Phenylpropanoid Biosynthesis. Molecular Plant 2010; 3 (1): 2-20.
34. Rice-Evans CA, Miller NJ and Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996; 20: 933-56.
35. De Groot H and Rauen U. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin. Pharmacol. 1998; 12: 249-55.
36. Middleton EJ. Effect of plant flavonoids on immune and inflammatory cell function. Adv. Exp. Med. Biol. 1998; 439: 175-82.
37. De Groot H. Reactive oxygen species in tissue injury. Hepatogastroenterol. 1994; 41: 328-32.
38. Waisundara VY, Hsu A, Huang D and Tan BK. Scutellaria baicalensis enhances the antidiabetic activity of metformin in streptozotocininduced diabetic Wistar rats. Am. J. Chin. Med. 2008; 36: 517-40.
39. Korkina LG, Afanas'ev IB. Antioxidant and chelating properties of flavonoids. Adv. Pharmacol. 1997; 38: 151-63.
40. Huk I, Brovkovych V and Nanobash VJ. Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemiareperfusion injury: an experimental study. Br. J. Surg. 1998; 85: 1080-5.
41. Sanhueza J, Valdes J, Campos R, Garrido A and Valenzuela A. Changes in the xanthine dehydroge-nase/xanthine oxidase ratio in the rat kidney subjected to ischemia-reperfusion stress: preventive effect of some flavonoids. Res. Commun. Chem. Pathol. Pharmacol. 1992; 78: 211-8.
42. Friesenecker B, Tsai AG, Allegra C and Intaglietta M. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: in vivo observations in the hamster skin fold. Int. J. Microcirc. Clin. Exp. 1994; 14: 50-5.
43. Ferrandiz ML, Gil B and Sanz MJ. Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice. J. Pharm. Pharmacol. 1996; 48: 975-80.
44. Friesenecker B, Tsai AG and Intaglietta M. Cellular basis of inflammation, edema and the activity of Daflon 500 mg. Int. J. Microcirc. Clin. Exp. 1995; 15: 17-21.
45. Ferrandiz ML and Alcaraz MJ. Antiinflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Actions 1991; 32: 283-8.
46. Ferrali M, Signorini C and Caciotti B. Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity. FEBS Lett. 1997; 416: 123-9.
47. Hii CS and S.L H. Effects of flavonoids on insulin secretion and Ca2+ handling in rat islets of Langerhans. J. Endocrinol. 1985; 107: 1-8.
48. Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comparative Biochemistry and Physiology C: Toxicol. Pharmacol. 2003; 135: 357-64.
49. Liu L, Liou SS and Cheng JT. Mediation of β-endorphin by myricetin to lower plasma glucose in streptozotocin-induced diabetic rats. Ethnopharmacol. 2006; 104: 199-206.
50. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA and Shay N. Soy isoflavones exert hypoglycemic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J. Nutrition 2003; 133: 1238-43.
51. Jung UJ, Lee MK, Jeong KS and Choi MS. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucoseregulating, enzymes in C57BL/KsJ-db/db mice. J. Nutrition 2004; 134: 2499-503.
52. Zhang J and Kashket S. Inhibition of salivary amylase by black and green teas and their effects on the intraoral hydrolysis of starch. Caries Res. 1998; 32: 233.
53. Rizvi SI, Abu Zaid M and Suhail M. Insulinmimetic effect of (-) epicatechin on osmotic fragility of human erythrocytes. Indian J. Exp. Biol. 1995; 33: 791-2.
54. Abu Zaid M, Sharma KK and Rizvi SI. Effect of (-) Epicatechin In Modulating Calicum-Atpase Activity In Normal and Diabetic Human Erythrocytes. Indian J. Clin. Biochem. 2002; 17: 27-32.
55. Davis FB, Davis P, Nat G, Blas SD, MacGillivray M, Gutman S, et al. The effect of in vivo glucose administration on human erythrocyte Ca++-ATPase activity on enzyme responsiveness in vitro to thyroid hormone and calmodulin. Diabetes 1985; 3693-6464.
56. Rizvi SI and Zaid MA. Insulin-Like Effect of (-) Epicatechin on Erythrocyte Membrane Acetylcholinesterase Activity In Type 2 Diabetes Mellitus. Clin. Experiment. Pharmacol. Physiol. 2001; 28: 776-8.
57. Rizvi SI and Zaid MA. Impairment of sodium pump and Na/H exchanger in erythrocytes from non-insulin dependent diabetes mellitus patients: effect of tea catechins. Clin. Chim. Acta. 2005; 354: 59-67.
58. Ganapathy V and Leibach FH. Proton and regulation of biological functions. Kidney Int. 1995; 40: S4-S10.
59. Cukiernik M, Hileeto D, Downey D, Evans T, Khan ZA, Karmazyn M, et al. The role of the sodium hydrogen exchanger-1 in mediating diabetes-induced changes in the retina. Diabetes Metab. Res. Rev. 2004; 20: 61-71.
60. Rizvi SI and Zaid MA. Intracellular reduced glutathione content in normal and type 2 diabetic erythrocytes: effect of insulin and (-) Epicatechin. J. physiol. Pharmacol. 2001; 52: 483-8.
61. Vijayalingam S, Partibhan A, Shamugasundaram R and Mohan V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet. Med. 1996; 13: 715-9.
62. Tsuda T, Horio F, Uchida K, Aoki H, Osawa T. Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J. Nutr. 2003; 133: 2125-30.
63. Tsuda T, Ueno Y, Kojo H, Yoshikawa T and Osawa T. Gene expression profile of isolated rat adipocytes treated with anthocyanins. Biochim. Biophys. Acta 2005; 1733: 137-47.
64. Tsuda T, Ueno Y, Yoshikawa T, Kojo H and Osawa T. Microarray profiling of gene expression in human adipocytes in response to anthocyanins. Biochem. Pharmacol. 2006; 71: 1184-97.
65. Zhang Y, Jayaprakasam B, Seeram NP, Olson LK, DeWitt D, Nair MG. Insulin secretion and cyc-looxygenase enzyme inhibition by cabernet sauvignon grape skin compounds. J. Agric. Food Chem. 2004; 52: 228-33.
66. Matsui T, Ueda T, Oki T, Sugita K, Terahara N and Matsumoto K. Alpha-Glucosidase inhibitory action of natural acylated anthocyanins. Survey of natural pigments with potent inhibitory activity. J. Agric. Food Chem. 2001; 49: 1948-51.
67. Pari L and Rajarajeswari N. Efficacy of coumarin on hepatic key enzymes of glucose metabolism in chemical induced type 2 diabetic rats. Chemico-Biological Interact. 2009; 181: 292-6.
68. Hung LM, Su MJ and Chen JK. Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms. Free Rad. Biol. Med. 2004; 36: 774-81.
69. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004; 24: 2783-840.
70. Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Sener M, et al. Neuroprotection by resveratrol against traumatic brain injury in rats. Mol. Cell Biochem. 2007; 294: 137-44.
71. Chi TC, Chen WP, Chi TL, Kuo TF, Lee SS, Cheng JT, et al. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci. 2007; 80: 1713-20.
72. Liu M, Chen WC, Cheng JT. Mediation of β-Endorphin by Isoferulic Acid to Lower Plasma Glucose in Streptozotocin-Induced Diabetic Rats. JPET. 2003; 307: 1196-204.
73. Sato M, Tai T, Nunoura Y and Yajima Y. Dehydrotrametenolic Acid Induces Preadipocyte Differentiation and Sensitizes Animal Models of Noninsulin-Dependent Diabetes Mellitus to Insulin. Biol. Pharm. Bull. 2002; 25: 81-6.
74. Greenfield JR and Chisholm DJ. Thiazolidinediones-mechanisms of action. Aust. Prescr. 2004; 27: 67-70.
75. Schoonjans K and Auwerx J. Thiazolidinediones: an update. Lancet 2000; 355: 1008-10.
76. Gurnell M, Savage DB, Chatterjee VK and O'Rahilly S. The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation. J. Clin. Endocrinol. Metab. 2003; 88: 2412-21.
77. Cantley LC. The phosphoinositide 3-kinase pathway. Sci. 2002; 296: 1655-7.
78. Sano H, Kane S, Sano E, Miinea CP, Asara JM, Lane WS, et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 2003; 278: 14599-602.
79. Zeigerer A, McBrayer MK and McGraw TE. Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. Mol. Biol. Cell 2004; 15: 4406-15.
80. Zhang Z, Li X, Lv W and Yang Y. Ginsenoside Re Reduces Insulin Resistance through Inhibition of c-Jun NH2-Terminal Kinase and Nuclear Factor-κB. Mol. Endocrinol. 2008; 22: 186-95.
81. Luo JZ and Luo L. American ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling protein-2 in cultured beta cells. Evid Based Complement. Alternat. Med. 2006; 365-72.
82. Hagen T and Vidal-Puig A. Mitochondrial uncoupling proteins in human physiology and disease. Minerva Med. 2002; 93: 41-57.
83. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat. Genet. 1997; 15: 269-72.
84. Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegeneration: Cause, effect, or association? J. Clin. Invest. 2003; 111: 163-9.
85. Lenaz G. The mitochondrial production of reactive oxygen species: Mechanisms and implications in human pathology. IUBMB Life 2001; 52: 159-64.
86. Goglia F and Skulachev VP. A function for novel uncoupling proteins: Antioxidant defense of mitochondrial matrix by translocating fatty acid peroxides from the inner to the outer membrane leaflet. FASEB J. 2003; 17: 1585-91.
87. Wang H, Chu WS, Lu T, Hasstedt SJ, Kern PA and Elbein SC. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity and insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2004; 286: E1-E7.
88. Krempler F, Esterbauer H and Weitgasser R. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 2002; 51: 3331-5.
89. Ashcroft FM, Proks P, Smith PA, Ammala C, Bokvist K and Rorsman P. Stimulus-secretion coupling in pancreatic beta cells. J. Cell Biochem. 1994; 55: 54-65.
90. Degerman E, Smith CJ, Tornqvist H, Vasta V, Belfrage P and Manganiello VC. Evidence that insulin and isoprenaline activate the cGMPinhibited low-Km cAMP phosphodiesterase in rat fat cells by phos-phorylation. Proc. Natl. Acad. Sci. 1990; 87: 533-7.
91. Rahn T, Ridderstrale M, Tornqvist H, Manganiello V, Fredrikson G, Belfrage P, et al. Essential role of phosphatidylinositol 3-kinase in insulininduced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes. Studies using the selective inhibitor wortmannin. FEBS Lett. 1994; 350: 314-8.
92. Wijkander J, Landstrom TR, Manganiello V, Belfrage P, Degerman E. Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase. Endocrinol. 1998; 139: 219-27.
93. Wang H, Reaves LA and Edens NK. Ginseng Extract Inhibits Lipolysis in Rat Adipocytes In Vitro by Activating Phosphodiesterase 4. J. Nutr. 2006; 136: 337-42.
94. Campbell PJ, Carlson MG, Hill JO, Nurjhan N. Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification. Am. J. Physiol. 1992; 263: E1063-9.
95. Edens NK, Reaves LA and Henry DE. Extract of ginseng (Panax ginseng) stimulates glucose transport and inhibits lipolysis in vitro. Diabetes 2001; 50: A413.
96. Li L, Jiao L and Lau BH. Protective effect of gypenosides against oxidative stress in phagocytes, vascular endothelial cells, and liver microsomes. Cancer Biother. 1993; 8: 263-72.
97. Lin JM, Lin CC, Chiu HF, Yang JJ and Lee SG. Evaluation of the anti-inflammatory and liverprotective effects of Anoectochilus formosanus, Ganoderma lucidum, and Gynostemma pentaphyllum in rats. Am. J. Chin. Med. 1993; 21: 59-69.
98. Aktan F, Henness S, Roufogalis BD and Ammit AJ. Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-kappaBmediated iNOS protein expression. Nitric Oxide 2003; 8: 235-42.
99. Rajaian H, Jalaee J and Aghajani A. Berberis vulgaris as Growth Promoter in Broiler Chickens. Int. J. Poultry Sci. 2006; 5: 395-7.
100. Singh SS, Pandey SC, Srivastava S, Gupta VS, Patro B and Ghosh AC. Chemistry and medicinal properties of Tinospora cordifolia (Guduchi). Indian J. Pharmacol. 2003; 35: 83-91.
101. Cheng Z, Pang T, Gu M and Gao A. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim. Biophys. Acta 2006; 1760: 1682-9.
102. Krook A, Wallberg-Henriksson H, Zierath Jr. Sending the signal: molecular mechanisms regulating glucose uptake. Med. Sci. Sports Exerc. 2004; 36: 1212-7.
103. Michelle Furtado L, Poon V, Klip A. GLUT4 activation: thoughts on possible mechanisms. Acta Physiol. Scand. 2003; 178: 287-96.
104. Wink M. Plant breeding: importance of plant secondary metabolites for protection against pathogens and herbivores. Theor. Appl. Genet. 1988; 75: 225-33.
105. Garci'a Lo'pez PM, Garzo'n de la Mora P, Wysocka W and Maiztegui B. Quinolizidine alkaloids isolated from Lupinus species enhance insulin secretion. Eur. J. Pharmacol. 2004; 504: 139-42.
106. Yuan ZM, He PM, Cui JH and Takeuchi H. Hypoglycemic effect of water-soluble polysaccharide from Auricularia auricula-judae Quel. on genetically diabetic KK-A (y) mice. Biosci. Biotech. Biochem. 1998; 62: 1903-89.
107. Luo Q, Cai Y, Yan J, Sun M and Corke H. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004; 76: 137-49.
108. Quanhong L, Caili F, Yukui R, Guanghui H and Tongyi C. Effects of Protein-Bound Polysaccharide Isolated from Pumpkin on Insulin in Diabetic Rats. Plant Foods Hum. Nutr. 2005; 60: 13-6.
109. Floyd JC, Fajans SS, Knopf RF and Conn JW. Evidence that insulin release is the mechanism for expe-rimentally induced leucine hypoglycemia in man. J. Clin. Invest. 1963; 42: 1714-9.
110. Milner RDG. The stimulation of insulin release by essential amino acids from rabbit pancreas in vitro. J. Endocr. 1970; 47: 347-56.
111. Sanchez-Andrés JV, Gomis A and Valdeolmillos M. The electrical activity of mouse pancreatic β-cells recorded in vivo shows glucosedependent oscillations. J. Physiol. 1995; 486: 223-8.
112. Bolea S, Pertusa JAG, Martín F, Sanchez- Andrés JV and Soria B. Regulation of pancreatic β-cell electrical activity and insulin release by physiological amino acid concentrations. Pflügers Arch.-Eur. J. Physiol. 1997; 433: 699-704.
113. Kumari K, Mathew BC and Augusti KT. Antidiabetic and hypolipidaemic effects of S-methyl cysteine sulfoxide, isolated from Allium cepa Linn. Ind. J. Biochem. Biophys. 1995; 32: 49-54.
114. Sheela CG and Augusti KT. Hypoglycemic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn. Ind. J. Exper. Biol. 1992; 30: 523-6.
115. Rabinkov A, Miron T, Konstantinovski L, Wilchek M, Mirelman D and Weiner L. The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim. Biophys. Acta 1998; 1379: 233-44.
116. Campos KE, Diniz YS, Cataneo AC, Faine LA, Alves MJ and Novelli EL. Hypoglycemic and antioxidant effect of onion, Allium cepa: dietary onion addition, antioxidant effect and hypoglycemic effects on diabetic rats. Int. J. Food Sci. Nutr. 2003; 54: 241-6.
117. Augusti KT and Shella CG. Antiperoxide effect of S-allyl cysteine sulfoxide, an insulin secretagogue in diabetic rats. Experientia 1996; 52: 115-20.
118. Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ and Banasadegh S. The improvement effect of L-Lys as a chemical chaperone on STZinduced diabetic rats, protein structure and function. Diab. Metab. Res. Rev. 2008; 24: 64-73.
119. Garcia-Olmo DC, Riese HH, Escribano J, Ontanon J, Fernandez JA and Atienzar M. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rat. Nutr. Cancer 1999; 35: 120-6.
120. Bathaei SZ and Ashori M. Effects of saffron aqueous extract on some biochemical factors of serum in streptozotocin-induced diabetic rats. Iran. J. Medicin.Aromat. Plants 2012, Under publication.
121. Shir-Ali S and Bathaie SZ. Study on the effects of saffron aqueous extract and crocin on diabetic rats. The National Conference of saffron in medicines and food; Gonabad, 2011.
122. Shir-Ali S, Bathaie SZ and nakhjavani M. Effects of saffron aqueous extract on biochemical factors of serum in streptozotocin-induced diabetic rats. 11th Congress of Biochem. Mol. Biol. 2011, Qazvin, Iran.
123. Bathaie SZ and Mousavi SZ. New Applications and Mechanisms of Action of Saffron and its Important Ingredients. Crit. Rev. Food Sci. Nutr. 2010; 50: 761-86.
124. Nelson RW, Ihle SL, Lewis LD, Salisbury SK, Miller T, Bergdall V, et al. Effects of dietary fiber supplementation on glycemic control in dogs with alloxan-induced diabetes mellitus. Am. J. Vet. Res. 1991; 52: 2060-6.
125. Madar Z, Abel R, Samish S and Arad J. Glucose-lowering effect of fenugreek in noninsulin dependent diabetics. Eur. J. Clin. Nutr. 1988; 42: 51-4.
126. Kahlon T, Chow FI, Knuckles BE and Chiu MM. Cholesterollowering effects in hamsters of ß-glucan-enriched barley fraction, dehulled whole barley, rice bran and oat bran and their combinations. Cereal Chem. 1993; 70: 435-42.
127. De Paula ACCFF, Sousa RV, Figueiredo- Ribeiro RCL, Buckeridge MS. Hypoglycemic activity of polysaccharide fractions containing ßglucans from extracts of Rhynchelytrum repens (Willd) C.E. Hubb., Poaceae. Brazil. J. Med. Biol. Res. 2005; 38: 885-93.
128. Anderson JW, Akanji AO. Treatment of diabetes with high fiber diet. In: Spiller GA (Editor) HoDFiHNCP, Boca Raton, FL, USA. 1993.
129. Hui H, Tang G and Go VL. Hypoglycemic herbs and their action mechanisms. Chinese Med. 2009; 4: 11.
130. Bailey CJ, Path MRC and Turner RC. Review Articles. N. Engl. J. Med. 1996; 334: 5-75.
131. Mukherjee PK, Maiti K, Mukherjee K and Houghton PJ. Leads from Indian medicinal plants with hy-poglycemic potentials. J. Ethnopharmacol. 2006; 106: 12.
132. Aktan F, Henness SH, Roufogalis BD and Ammit AJ. Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-jB-mediated iNOS protein expression. Nitric Oxide 2003; 8: 236.
133. Matsuura H, Kasai R, Tanaka O, Saruwatari Y, Kunihiro K and Fuwa T. Further studies on the dammarane-saponins of ginseng roots. Chem. Pharm. Bull. 1984; 32: 1188-92.
134. Smet PA. Herbal remedies. N. Engl. J. Med. 2002; 347: 2046-56.